Gsk Share Discussion Threads

[zeppo] 06/6/2020 12:21

Hope you are right, abdulla, but you are asking us to wait for an illusion.

The dividends have been good at 80p per share, for years now.

But when will they be able increase the dividends?

[abdullla] 06/6/2020 11:40

You never know GSK might pull the rabbit out of the hat yet .

[riz000] 05/6/2020 15:27

I am the Riz Raskal King of the TAJ MAHAL saith thus:-
Riz tires of the speculation panics ramping and de ramping on these boards

Azn piece of $hit going down n out

[grahamburn] 05/6/2020 15:17

Meanwhile Astra Zeneca are getting the lion's share of publicity in this country around COVID. Pascal Soiret is a competent media performer.

[montyhedge] 05/6/2020 09:37

Of course shareprice won't do much, below what it was 22 years ago, be in the same in another 22 years below this price, no growth whatsoever, its really a corporate bond in disquise, paying 4.5% dividend.

[ric0chet] 05/6/2020 09:11

can't see the share price doing much but retrace lower until the results on 22nd July and then...

[abdullla] 04/6/2020 15:41

GSK is a worlds biggest vaccine provider but its current performance is well below other pharmas,why ?

[abdullla] 04/6/2020 10:07

GSK has only the Adjuvant which they will assist Sanofi with who is making the vaccine,SP now going down.

[geckotheglorious] 04/6/2020 09:08

They could always come in round the outside in the final furlong....
:)

[montyhedge] 04/6/2020 08:25

So GSK not on the list.

[geckotheglorious] 03/6/2020 19:52

White House picks five COVID vaccine candidates for Warp Speed initiative
Jun. 3, 2020 1:28 PM ET|About: Moderna, Inc. (MRNA)|By: Douglas W. House, SA News Editor
Aimed at following through on its pledge to have a COVID-19 vaccine available in the next 2-3 quarters under Operation Warp Speed, the Trump administration has selected five "finalists" for development.

Moderna (MRNA +3.8%): Phase 2 study of mRNA-1273 underway.

AstraZeneca (AZN +0.5%) with Oxford University: Studies in UK underway on AZD1222.

Johnson & Johnson (JNJ -0.1%): Phase 1 study to launch in September at the latest.

Merck (MRK +1.6%): No dates yet announced for trials.

Pfizer (PFE -0.9%): "Hundreds of millions" of doses to be available this year.

MRNA, AZN/Oxford and JNJ have already received $2.2B in federal funding. All five will have access to additional financial support to quickly advance their candidates.

About 30K people will take part in Phase 3 trials, meaning that a total of 150K people could be vaccinated.

Conspicuous by their absence are GlaxoSmithKline (GSK +0.4%) and Sanofi (SNY -0.5%).

[geckotheglorious] 03/6/2020 19:51

White House picks five COVID vaccine candidates for Warp Speed initiative

Aimed at following through on its pledge to have a COVID-19 vaccine available in the next 2-3 quarters under Operation Warp Speed, the Trump administration has selected five "finalists" for development.

Moderna (MRNA +3.8%): Phase 2 study of mRNA-1273 underway.

AstraZeneca (AZN +0.5%) with Oxford University: Studies in UK underway on AZD1222.

Johnson & Johnson (JNJ -0.1%): Phase 1 study to launch in September at the latest.

Merck (MRK +1.6%): No dates yet announced for trials.

Pfizer (PFE -0.9%): "Hundreds of millions" of doses to be available this year.

MRNA, AZN/Oxford and JNJ have already received $2.2B in federal funding. All five will have access to additional financial support to quickly advance their candidates.

About 30K people will take part in Phase 3 trials, meaning that a total of 150K people could be vaccinated.

Conspicuous by their absence are GlaxoSmithKline (GSK +0.4%) and Sanofi (SNY -0.5%).

[rikky72] 03/6/2020 14:45

No MMs here as it's all done automatically given the volumes involved..

[abdullla] 03/6/2020 09:48

MMs will drop the share price by 10p every day.

[arja] 02/6/2020 14:04

yes pharmas hit today and even AZN ! maybe a rally after lead market for this stock
opens at 2.20pm .

[abdullla] 02/6/2020 14:01

All safe heaven shares going down .

[gateside] 01/6/2020 16:41

AZN up 1.4%GSK down 0.6%Same old story!

[montyhedge] 01/6/2020 09:52

It's underperformed for 22 years, still below what it was 22 years ago.Next 22 years will be the same. GSK is not a growth stock.

[spoole5] 01/6/2020 09:11

Underperforming again

[bountyhunter] 29/5/2020 09:30

hold a few of these but topped up with AZN this morning as they seem to have the edge on many fronts (except Divi)

[abdullla] 29/5/2020 08:37

Yesterday's rise soon to disappear

[alphorn] 28/5/2020 13:12

Yes, that sounds the 'clever' bit. Let others look for the vaccine. Business???

[quepassa] 28/5/2020 13:11

but it's the vast quantities involved - and applicable to whichever vaccines are untimately found/approved

[alphorn] 28/5/2020 13:05

Here is the clickable link:



Interesting approach for a product - not a vaccine itself though.

[quepassa] 28/5/2020 13:01

GSK to produce a billion doses of COVID-19 vaccine booster by 2021.

See full 28/5 article here


hXXps://pharmaphorum.com/news/gsk-to-produce-a-billion-doses-of-covid-19-vaccine-booster-by-2021/

ALL IMO. DYOR.
QP